Fumiharu Ohka

4.0k citations
99 papers · 1.8k indexed · h-index 23
Topics
Glioma Diagnosis and Treatment (56 papers)Meningioma and schwannoma management (19 papers)MicroRNA in disease regulation (11 papers)

In The Last Decade

Fumiharu Ohka

87 papers receiving 1.8k citations

Peers

Fumiharu Ohka
Comparison fields: 5 of 98
  • Molecular Biology 1.0k
  • Cancer Research 678
  • Genetics 525
  • Oncology 309
  • Epidemiology 188
Replace Bryan W. Day with:
Bryan W. Day Australia
Ana C. deCarvalho United States
Patrick Y Wen United States
Armida W. M. Fabius Netherlands
Giselle Y. López United States
Kelly Burrell Canada
Markus J. Riemenschneider Germany
Luca Persano Italy
Helle Broholm Denmark
Carsten Hagemann Germany
Fumiharu Ohka relative to Bryan W. Day Australia Bryan W. Day's profile →
Citations per field
00.5×1.5×2.4×
Bryan W. Day · 1×
Citations per year

Countries citing papers authored by Fumiharu Ohka

Since Specialization
Citations

This map shows the geographic impact of Fumiharu Ohka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumiharu Ohka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumiharu Ohka more than expected).

Fields of papers citing papers by Fumiharu Ohka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fumiharu Ohka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumiharu Ohka. The network helps show where Fumiharu Ohka may publish in the future.

Co-authorship network of co-authors of Fumiharu Ohka

This figure shows the co-authorship network connecting the top 25 collaborators of Fumiharu Ohka. A scholar is included among the top collaborators of Fumiharu Ohka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumiharu Ohka. Fumiharu Ohka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 0
3 1
4 0
5 17
6 10
7 28
8 0
9 1
10 6
11 3
12 15
13 15
14 45
15 80
16 261
17 40
18 12
19 79
20 32

About Fumiharu Ohka

Fumiharu Ohka is a scholar working on Genetics, Cancer Research and Neurology, having authored 99 papers that have together received 1.8k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (56 papers), Meningioma and schwannoma management (19 papers) and MicroRNA in disease regulation (11 papers). The work is most often cited by research in Genetics (525 citations), Cancer Research (678 citations) and Molecular Biology (1.0k citations). Fumiharu Ohka has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Atsushi Natsume, Toshihiko Wakabayashi, Yutaka Kondo, Kazuya Motomura, Keiko Shinjo, Keisuke Katsushima, Akira Hatanaka, Kuniaki Tanahashi, Kosuke Aoki and Shinya Sato. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026